Judge Chides FDA For Stalling Otsuka's Abilify Suit
A Maryland federal judge on Wednesday rebuked the U.S. Food and Drug Administration over its attempt to derail high-profile litigation involving exclusivity for Otsuka Pharmaceutical Co. Ltd.'s blockbuster antipsychotic Abilify, accusing...To view the full article, register now.
Already a subscriber? Click here to view full article